Kathryn S. Jones

Kathryn S. Jones

Auto-generated profile, based on publicly available information

Kathryn S. Jones


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2008 in Nature Medicine
Verified
Journal Article
Closed access
KJKathryn S Jones
Kathryn S Jones
CPCari Petrow-Sadowski
Cari Petrow-Sadowski
YHYing K Huang
Ying K Huang
DBDaniel C Bertolette
Daniel C Bertolette
FRFrancis W Ruscetti
Francis W Ruscetti

21 May 2009 in Blood
Verified
Journal Article
Open access
PDF file
SLSophie Lambert
Sophie Lambert
MBManuella Bouttier
Manuella Bouttier
RVRoger Vassy
Roger Vassy
MSMichel Seigneuret
Michel Seigneuret
CPCari Petrow-Sadowski
Cari Petrow-Sadowski
Claudine PiqueClaudine Pique
Claudine Pique
Human T-cell lymphotropic virus type 1 (HTLV-1) entry involves the interaction between the surface (SU) subunit of the Env proteins and cellular receptor(s). Previously, our laboratories demonstrated that heparan sulfate proteoglycans (HSPGs) and neuropilin-1 (NRP-1), a receptor of VEGF165, are essential for HTLV-1 entry. Here we investigated whether, as when binding VEGF165, HSPGs and NRP-1 work in concert during HTLV-1 entry. VEGF165 binds to the b domain of NRP-1 through both HSPG-dependent and -independent interactions, the latter involving its exon 8. We show that VEGF165 is a selective competitor of HTLV-1 entry and that HTLV-1 mimics VEGF165 to recruit HSPGs and NRP-1: (1) the NRP-1 b domain is required for HTLV-1 binding; (2) SU binding to target cells is blocked by the HSPG-binding domain of VEGF165; (3) the formation of Env/NRP-1 complexes is enhanced by HSPGs; and (4) the HTLV SU contains a motif homologous to VEGF165 exon 8. This motif directly binds to NRP-1 and is essential for HTLV-1 binding to, internalization into, and infection of CD4+ T cells and dendritic cells. These findings demonstrate that HSPGs and NRP-1 function as HTLV-1 receptors in a cooperative manner and reveal an unexpected mimicry mechanism that may have major implications in vivo.

1 January 2012 in Frontiers in Microbiology
Verified
Journal Article
Open access
Claudine PiqueClaudine Pique
Claudine Pique
KJKathryn S. Jones
Kathryn S. Jones
The deltaretroviruses human T cell lymphotropic virus type 1 (HTLV-1) and human T cell lymphotropic virus type 2 (HTLV-2) have long been believed to differ from retroviruses in other genera by their mode of transmission. While other retroviruses were thought to primarily spread by producing cell-free particles that diffuse through extracellular fluids prior to binding to and infecting target cells, HTLV-1 and HTLV-2 were believed to transmit the virus solely by cell–cell interactions. This difference in transmission was believed to reflect the fact that, relative to other retroviruses, the cell-free virions produced by HTLV-infected cells are very poorly infectious. Since HTLV-1 and HTLV-2 are primarily found in T cells in the peripheral blood, spread of these viruses was believed to occur between infected and uninfected, T cells, although little was known about the cellular and viral proteins involved in this interaction. Recent studies have revealed that the method of transmission of HTLV is not unique: other retroviruses including human immunodeficiency virus (HIV) are also transmitted from cell-to-cell, and this method is dramatically more efficient than cell-free transmission. Moreover, cell–cell transmission of HTLV-1, as well as HIV, can occur following interactions between dendritic cells and T cells, as well as between T cells. Conversely, other studies have shown that cell-free HTLV-1 is not as poorly infectious as previously thought, since it is capable of infecting certain cell types. Here we summarize the recent insights about the mechanisms of cell–cell transmission of HTLV-1 and other retroviruses. We also review in vitro and in vivo studies of infection and discuss how these finding may relate to the spread of HTLV-1 between individuals.

1 September 2006 in Journal of Virology
Verified
Journal Article
Closed access
KJKathryn S. Jones
Kathryn S. Jones
KFKazunori Fugo
Kazunori Fugo
CPCari Petrow-Sadowski
Cari Petrow-Sadowski
YHYing Huang
Ying Huang
DBDaniel C. Bertolette
Daniel C. Bertolette
FRFrancis W. Ruscetti
Francis W. Ruscetti
Studies using adherent cell lines have shown that glucose transporter-1 (GLUT-1) can function as a receptor for human T-cell leukemia virus type 1 (HTLV). In primary CD4 + T cells, heparan sulfate proteoglycans (HSPGs) are required for efficient entry of HTLV-1. Here, the roles of HSPGs and GLUT-1 in HTLV-1 and HTLV-2 Env-mediated binding and entry into primary T cells were studied. Examination of the cell surface of activated primary T cells revealed that CD4 + T cells, the primary target of HTLV-1, expressed significantly higher levels of HSPGs than CD8 + T cells. Conversely, CD8 + T cells, the primary target of HTLV-2, expressed GLUT-1 at dramatically higher levels than CD4 + T cells. Under these conditions, the HTLV-2 surface glycoprotein (SU) binding and viral entry were markedly higher on CD8 + T cells while HTLV-1 SU binding and viral entry were higher on CD4 + T cells. Binding studies with HTLV-1/HTLV-2 SU recombinants showed that preferential binding to CD4 + T cells expressing high levels of HSPGs mapped to the C-terminal portion of SU. Transfection studies revealed that overexpression of GLUT-1 in CD4 + T cells increased HTLV-2 entry, while expression of HSPGs on CD8 + T cells increased entry of HTLV-1. These studies demonstrate that HTLV-1 and HTLV-2 differ in their T-cell entry requirements and suggest that the differences in the in vitro cellular tropism for transformation and in vivo pathobiology of these viruses reflect different interactions between their Env proteins and molecules on CD4 + and CD8 + T cells involved in entry.

15 June 2011 in Viruses
Verified
Journal Article
Open access
PDF file
KJKathryn S. Jones
Kathryn S. Jones
SLSophie Lambert
Sophie Lambert
MBManuella Bouttier
Manuella Bouttier
LBLaurence Bénit
Laurence Bénit
FRFrank W. Ruscetti
Frank W. Ruscetti
Claudine PiqueClaudine Pique
Claudine Pique
The initial step in retroviral infection involves specific interactions between viral envelope proteins (Env) and specific receptors on the surface of target cells. For many years, little was known about the entry receptors for HTLV-1. During this time, however, functional domains of the HTLV-1 Env were identified by analyzing the effects of neutralizing antibodies and specific mutations in Env on HTLV-1 infectivity. More recent studies have revealed that HTLV-1 infectivity involves interactions with three different molecules: heparan sulfate proteoglycans (HSPG), the VEGF-165 receptor Neuropilin 1 (NRP-1) and glucose transporter type 1 (GLUT1). Here, we revisit previously published data on the functional domains of Env in regard to the recent knowledge acquired about this multi-receptor complex. We also discuss the similarities and differences between HTLV-1 and other deltaretroviruses in regards to receptor usage.

29 November 2010 in Retrovirology
Verified
Journal Article
Open access
PDF file
DGDavid Ghez
David Ghez
YLYves Lepelletier
Yves Lepelletier
KJKathryn S Jones
Kathryn S Jones
Claudine PiqueClaudine Pique
Claudine Pique
OHOlivier Hermine
Olivier Hermine
The identity of the Human T lymphotropic Virus type 1 (HTLV-1) receptor remained an unsolved puzzle for two decades, until the recent demonstration that three molecules, Glucose Transporter 1, Neuropilin-1 and Heparan Sulfate Proteoglycans are involved in HTLV-1 binding and entry. Despite these advances, several questions remain unanswered, including the precise role of each of these molecules during virus entry. In light of the most recent data, we propose a model of the HTLV-1 receptor complex and discuss its potential impact on HTLV-1 infection.